Annual EBITDA
-$41.44 M
+$52.09 M+55.70%
December 31, 2023
Summary
- As of March 7, 2025, ELEV annual EBITDA is -$41.44 million, with the most recent change of +$52.09 million (+55.70%) on December 31, 2023.
- During the last 3 years, ELEV annual EBITDA has fallen by -$24.17 million (-140.05%).
- ELEV annual EBITDA is now -140.05% below its all-time high of -$17.26 million, reached on December 31, 2020.
Performance
ELEV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.22 M
-$2.27 M-20.67%
September 30, 2024
Summary
- As of March 7, 2025, ELEV quarterly EBITDA is -$13.22 million, with the most recent change of -$2.27 million (-20.67%) on September 30, 2024.
- Over the past year, ELEV quarterly EBITDA has stayed the same.
- ELEV quarterly EBITDA is now -575.04% below its all-time high of -$1.96 million, reached on March 31, 2020.
Performance
ELEV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$43.11 M
-$2.31 M-5.67%
September 30, 2024
Summary
- As of March 7, 2025, ELEV TTM EBITDA is -$43.11 million, with the most recent change of -$2.31 million (-5.67%) on September 30, 2024.
- Over the past year, ELEV TTM EBITDA has stayed the same.
- ELEV TTM EBITDA is now -2100.82% below its all-time high of -$1.96 million, reached on March 31, 2020.
Performance
ELEV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ELEV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.7% | 0.0% | 0.0% |
| 3 y3 years | -140.1% | +24.6% | +53.9% |
| 5 y5 years | - | +24.6% | +53.9% |
ELEV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.4% | +55.7% | -45.8% | +65.7% | -34.6% | +53.9% |
| 5 y | 5-year | -140.1% | +55.7% | -575.0% | +65.7% | -2100.8% | +53.9% |
| alltime | all time | -140.1% | +55.7% | -575.0% | +65.7% | -2100.8% | +53.9% |
Elevation Oncology EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.22 M(+20.7%) | -$43.11 M(+5.7%) |
| Jun 2024 | - | -$10.96 M(+11.2%) | -$40.80 M(+2.9%) |
| Mar 2024 | - | -$9.86 M(+8.7%) | -$39.67 M(-4.3%) |
| Dec 2023 | -$41.44 M(-55.7%) | -$9.07 M(-16.9%) | -$41.44 M(-17.0%) |
| Sep 2023 | - | -$10.91 M(+11.1%) | -$49.90 M(-35.6%) |
| Jun 2023 | - | -$9.82 M(-15.5%) | -$77.51 M(-11.7%) |
| Mar 2023 | - | -$11.63 M(-33.7%) | -$87.79 M(-6.1%) |
| Dec 2022 | -$93.53 M | -$17.53 M(-54.5%) | -$93.53 M(+9.2%) |
| Sep 2022 | - | -$38.52 M(+91.6%) | -$85.61 M(+44.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$20.11 M(+15.8%) | -$59.37 M(+34.0%) |
| Mar 2022 | - | -$17.36 M(+80.5%) | -$44.31 M(+38.3%) |
| Dec 2021 | -$32.03 M(+85.6%) | -$9.62 M(-21.6%) | -$32.03 M(+2.4%) |
| Sep 2021 | - | -$12.27 M(+142.9%) | -$31.28 M(+42.1%) |
| Jun 2021 | - | -$5.05 M(-0.6%) | -$22.02 M(+8.0%) |
| Mar 2021 | - | -$5.08 M(-42.7%) | -$20.38 M(+18.1%) |
| Dec 2020 | -$17.26 M | -$8.87 M(+194.6%) | -$17.26 M(+105.8%) |
| Sep 2020 | - | -$3.01 M(-11.9%) | -$8.39 M(+56.0%) |
| Jun 2020 | - | -$3.42 M(+74.5%) | -$5.38 M(+174.5%) |
| Mar 2020 | - | -$1.96 M | -$1.96 M |
FAQ
- What is Elevation Oncology annual EBITDA?
- What is the all time high annual EBITDA for Elevation Oncology?
- What is Elevation Oncology annual EBITDA year-on-year change?
- What is Elevation Oncology quarterly EBITDA?
- What is the all time high quarterly EBITDA for Elevation Oncology?
- What is Elevation Oncology quarterly EBITDA year-on-year change?
- What is Elevation Oncology TTM EBITDA?
- What is the all time high TTM EBITDA for Elevation Oncology?
- What is Elevation Oncology TTM EBITDA year-on-year change?
What is Elevation Oncology annual EBITDA?
The current annual EBITDA of ELEV is -$41.44 M
What is the all time high annual EBITDA for Elevation Oncology?
Elevation Oncology all-time high annual EBITDA is -$17.26 M
What is Elevation Oncology annual EBITDA year-on-year change?
Over the past year, ELEV annual EBITDA has changed by +$52.09 M (+55.70%)
What is Elevation Oncology quarterly EBITDA?
The current quarterly EBITDA of ELEV is -$13.22 M
What is the all time high quarterly EBITDA for Elevation Oncology?
Elevation Oncology all-time high quarterly EBITDA is -$1.96 M
What is Elevation Oncology quarterly EBITDA year-on-year change?
Over the past year, ELEV quarterly EBITDA has changed by $0.00 (0.00%)
What is Elevation Oncology TTM EBITDA?
The current TTM EBITDA of ELEV is -$43.11 M
What is the all time high TTM EBITDA for Elevation Oncology?
Elevation Oncology all-time high TTM EBITDA is -$1.96 M
What is Elevation Oncology TTM EBITDA year-on-year change?
Over the past year, ELEV TTM EBITDA has changed by $0.00 (0.00%)